Profil
David A. Giljohann is Chief Executive Officer at EVOQ Therapeutics, Inc. since 2023.
Former roles include Founding Scientist at Aurasense LLC, Chief Operating Officer & Principal Scientist at Exicure Operating Co. from 2012 to 2013, and Chief Technology Officer at Exicure, Inc. from 2021 to 2022.
Education includes undergraduate and doctorate degrees from Northwestern University.
Aktive Positionen von David Giljohann
| Unternehmen | Position | Beginn |
|---|---|---|
EVOQ Therapeutics, Inc.
EVOQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in developing new vaccine strategies for improving outcomes for cancer patients | Vorstandsvorsitzender | 01.01.2023 |
Ehemalige bekannte Positionen von David Giljohann
| Unternehmen | Position | Ende |
|---|---|---|
| EXICURE, INC. | Vorstandsvorsitzender | 10.12.2021 |
Aurasense LLC
Aurasense LLC BiotechnologyHealth Technology Engages in advanced nanotechnology solutions | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Vorstandsvorsitzender | - |
Ausbildung von David Giljohann
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Aurasense LLC
Aurasense LLC BiotechnologyHealth Technology Engages in advanced nanotechnology solutions | Health Technology |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Health Technology |
Exicure, Inc.
Exicure, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops nucleic acid therapies against to neurological disorders and hair loss | Health Technology |
EVOQ Therapeutics, Inc.
EVOQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in developing new vaccine strategies for improving outcomes for cancer patients | Health Technology |
















